Science & Innovation

Pioneering next-generation therapies through molecular precision. We integrate advanced biologics and novel small molecules to target complex disease pathways.

— Science & Innovation

Technology Platforms

Leveraging biologics and small molecules to target disease pathways with precision — from monoclonal antibodies to next-generation ADCs.

Biologics

Harnessing the power of the immune system to deliver highly targeted therapies. Our biologics platform focuses on next-generation monoclonal antibodies and precision ADCs designed to seek and destroy cancer cells

Learn more →

Small Molecules

Targeting disease at the intracellular level. Our small molecule platform is dedicated to discovering highly potent, orally bioavailable compounds capable of modulating critical disease pathways that larger therapies cannot reach.

Learn more →